Using circulating tumor DNA to identify patients at risk of
Read moreHome »
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab),
Read moreA team of Roswell Park Comprehensive Cancer Center researchers has
Read moreResearchers studying a large set of small cell lung cancer
Read moreThe interdisciplinary team of scientists from three different countries (Belgium,
Read moreA novel CAR T-cell therapy developed by researchers at UCL
Read moreThough cancer immunotherapy has become a promising standard-of-care treatment—and in
Read moreA ground-breaking new therapy that harnesses the body’s immune system
Read moreAs early responders in the surveillance of malignant cells, natural
Read moreAn international team involving Vanderbilt researchers has discovered that a
Read more